Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Current Medicinal Chemistry|June 8, 2018
Phytosterols in Cancer: From Molecular Mechanisms to Preventive and Therapeutic PotentialsFrancisco Blanco-Vaca, Lídia Cedó, Josep JulveMedicina Clinica|March 16, 2005
[Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease]Xavier Palomer, Antonio Pérez, Francisco Blanco-VacaMedicina Clinica|April 26, 2005
[Determination and utilisation of the plasmatic concentration of homocysteine in clinical practice]Joan Llevadot, Francisco Blanco Vaca, Francesc González SastreExpert Opinion on Drug Discovery|December 17, 2013
High-density lipoprotein cholesterol targeting for novel drug discovery: where have we gone wrong?Joan Carles Escolà-Gil, Lídia Cedó, Francisco Blanco-VacaThe British Journal of Nutrition|March 4, 2006
Phytosterol-mediated inhibition of intestinal cholesterol absorption is independent of ATP-binding cassette transporter A1Laura Calpe-Berdiel, Joan Carles Escolà-Gil, Francisco Blanco-VacaAtherosclerosis|August 12, 2008
New insights into the molecular actions of plant sterols and stanols in cholesterol metabolismLaura Calpe-Berdiel, Joan Carles Escolà-Gil, Francisco Blanco-VacaCurrent Vascular Pharmacology|December 15, 2010
Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosisJosep Julve, Gemma Llaverias, Francisco Blanco-Vaca, et al.Atherosclerosis|April 14, 2009
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotectionJoan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, et al.Revista De Neurologia|March 4, 2010
[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]Jesús Méndez-González, Elisabeth Rodríguez-Millán, Josep Julve, et al.Current Atherosclerosis Reports|April 29, 2021
Reverse Cholesterol Transport Dysfunction Is a Feature of Familial HypercholesterolemiaJoan Carles Escolà-Gil, Noemí Rotllan, Josep Julve, et al.Pageof 14